Atara Biotherapeutics (ATRA) Priced

Early-stage biotech targeting muscle loss in patients with end-stage renal disease.

Health Care - Biotechnology

IPO Performance
Latest Trade $14.95 -0.65 (-4.2%)
First Day Return -3.2%
Return from IPO 41.8%
 
Atara Biotherapeutics IPO News more
  • .
IPO Data
IPO File Date 06/20/2014
Offer Price $11.00
Price Range $14.00 - $16.00
Offer Shares (mm) 5.0
Deal Size ($mm) 55
 
IPO Data
IPO Date 10/15/2014
Offer Price $11.00
Price Range $14.00 - $16.00
Offer Shares (mm) 5.0
Deal Size ($mm) $55
 
Underwriters
more
Business Overview
Early-stage biotech targeting muscle loss in patients with end-stage renal disease.
Early-stage biotech targeting muscle loss in patients with end-stage renal disease.
more
Company Data
Headquarters Brisbane, CA
Founded 2012
Employees 15
Website www.atarabio.com
 

Performance vs. IPO Index (IPOUSA)